日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Case Report: Beyond metabolism: subclinical hypothyroidism associated with chronic alveolar hypoventilation

病例报告：超越代谢：亚临床甲状腺功能减退症与慢性肺泡低通气相关

期刊:Frontiers in Medicine
影响因子:3
doi:10.3389/fmed.2026.1759084
Prasad, Sai; Sharma, Shreya; Agrawal, Shaily; Nagda, Jay; Parmar, Vidhi; Bavaria, Deep; Kothia, Darpan; Dhaduk, Vidhi; Nada, Priyanshi; Vardhan, Harsh
代谢
甲状腺功能减退
免疫/内分泌
发表日期：2026
文献求助 收藏

Seizure and aspiration complicating acute expanding epidural hematoma in a tuberous sclerosis adolescent: a case report of clinical and surgical emergency

结节性硬化症青少年急性扩张性硬膜外血肿并发癫痫和误吸：一例临床和外科急症病例报告

期刊:BMC Neurology
影响因子:2.2
doi:10.1186/s12883-026-04662-6
Prasad, Sai; Agrawal, Shaily; Jangir, Amit; Nagda, Jay; Kothia, Darpan; Bavaria, Deep; Kumar, Prakruthi R U; Badjatiya, Bhumika
癫痫
神经科学
发表日期：2026
文献求助 收藏

Unexplained hypercapnia with normal pulmonary evaluation in a patient receiving semaglutide: a diagnostic challenge

接受索玛鲁肽治疗的患者出现不明原因的高碳酸血症，但肺部检查结果正常：诊断上的挑战

期刊:
影响因子:
doi:10.1210/jcemcr/luag121
Prasad, Sai; Ahuja, Aarushi; Katwa, Laxmansa C; Sharma, Shreya; Parmar, Vidhi; Agrawal, Shaily
发表日期：2026
文献求助 收藏

Case Report: Euglycemic ketoacidosis in a non-diabetic patient: a rare adverse effect of SGLT2 inhibitor therapy

病例报告：非糖尿病患者发生正常血糖性酮症酸中毒：SGLT2抑制剂治疗的一种罕见不良反应

期刊:Frontiers in Endocrinology
影响因子:4.6
doi:10.3389/fendo.2025.1746210
Prasad, Sai; Sharma, Shreya; Shetty, Rudrakshi; Singh, Snigdha; Parmar, Vidhi; Shivaprasad, Channabasappa; Dhaduk, Vidhi
SGLT2
糖尿病
代谢
发表日期：2025
文献求助 收藏

Paroxysmal Nocturnal Hemoglobinuria-Driven Hepatic Vein Thrombosis: A Case of Budd-Chiari Syndrome in Disguise

阵发性睡眠性血红蛋白尿诱发的肝静脉血栓形成：一例伪装的布加氏综合征

期刊:Cureus Journal of Medical Science
影响因子:1.3
doi:10.7759/cureus.97611
Agrawal, Shaily; Prasad, Sai; Nagda, Jay; Parmar, Vidhi; Reddy, Advaitha
心血管
发表日期：2025
文献求助 收藏

Phase III randomized clinical studies to evaluate the immunogenicity, lot-to-lot consistency, and safety of ROTAVAC® liquid formulations (ROTAVAC 5C & 5D) and non-inferiority comparisons with licensed ROTAVAC® (frozen formulation) in healthy infants

在健康婴儿中开展 III 期随机临床研究，以评估 ROTAVAC® 液体制剂（ROTAVAC 5C 和 5D）的免疫原性、批间一致性和安全性，并与已获许可的 ROTAVAC®（冷冻制剂）进行非劣效性比较。

期刊:Human Vaccines & Immunotherapeutics
影响因子:3.5
doi:10.1080/21645515.2023.2278346
P, Krishna Kumari; Chiteti, Siddharth Reddy; Aileni, Vinay K; Babji, Sudhir (late); Blackwelder, William C; Kumar, Ashok; Vagha, Jayant; Nayak, Uma; Mitra, Monjori; D, Narayanaappa; Kar, Sonali; Yadav, Sangeeta; Naidu, Swamy; Mahantshetti, Niranjan; Khalatkar, Vasant; Mohapatra, Satyajit; Purthi, P K; Sharma, Pawan; Kannan, A; Dhongade, Ramchandra Keshav; Prasad, Sai D; Ella, Raches; Vadrevu, Krishna Mohan
免疫/内分泌
发表日期：2023
文献求助 收藏

The Future of Epidemic and Pandemic Vaccines to Serve Global Public Health Needs

流行病和大流行疫苗的未来将如何满足全球公共卫生需求

期刊:Vaccines
影响因子:3.4
doi:10.3390/vaccines11030690
Farlow, Andrew; Torreele, Els; Gray, Glenda; Ruxrungtham, Kiat; Rees, Helen; Prasad, Sai; Gomez, Carolina; Sall, Amadou; Magalhães, Jorge; Olliaro, Piero; Terblanche, Petro
发表日期：2023
文献求助 收藏

Preclinical evaluation of safety and immunogenicity of a primary series intranasal COVID-19 vaccine candidate (BBV154) and humoral immunogenicity evaluation of a heterologous prime-boost strategy with COVAXIN (BBV152)

对鼻内新冠疫苗候选疫苗（BBV154）进行初级系列安全性和免疫原性的临床前评估，并对采用 COVAXIN（BBV152）的异源初免-加强免疫策略进行体液免疫原性评估。

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2022.1063679
Sunagar, Raju; Prasad, Sai D; Ella, Raches; Vadrevu, Krishna Mohan
微生物学
新冠
免疫/内分泌
发表日期：2022
文献求助 收藏

Indian Wheat Genomics Initiative for Harnessing the Potential of Wheat Germplasm Resources for Breeding Disease-Resistant, Nutrient-Dense, and Climate-Resilient Cultivars

印度小麦基因组学计划：利用小麦种质资源培育抗病、营养丰富、适应气候变化的品种

期刊:Frontiers in Genetics
影响因子:2.8
doi:10.3389/fgene.2022.834366
Kumar, Sundeep; Jacob, Sherry R; Mir, Reyazul Rouf; Vikas, V K; Kulwal, Pawan; Chandra, Tilak; Kaur, Satinder; Kumar, Uttam; Kumar, Suneel; Sharma, Shailendra; Singh, Ravinder; Prasad, Sai; Singh, Anju Mahendru; Singh, Amit Kumar; Kumari, Jyoti; Saharan, M S; Bhardwaj, Subhash Chander; Prasad, Manoj; Kalia, Sanjay; Singh, Kuldeep
发表日期：2022
文献求助 收藏

Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial

灭活SARS-CoV-2疫苗（BBV152）的有效性、安全性和批间免疫原性：一项随机、双盲、对照3期试验的中期结果

期刊:Lancet
影响因子:88.5
doi:10.1016/S0140-6736(21)02000-6
Ella, Raches; Reddy, Siddarth; Blackwelder, William; Potdar, Varsha; Yadav, Pragya; Sarangi, Vamshi; Aileni, Vinay K; Kanungo, Suman; Rai, Sanjay; Reddy, Prabhakar; Verma, Savita; Singh, Chandramani; Redkar, Sagar; Mohapatra, Satyajit; Pandey, Anil; Ranganadin, Pajanivel; Gumashta, Raghavendra; Multani, Manish; Mohammad, Shameem; Bhatt, Parul; Kumari, Laxmi; Sapkal, Gajanan; Gupta, Nivedita; Abraham, Priya; Panda, Samiran; Prasad, Sai; Bhargava, Balram; Ella, Krishna; Vadrevu, Krishna Mohan
SARS-CoV-2
免疫/内分泌
发表日期：2021
文献求助 收藏